Lista de obras - M Serino - Dominio Público Uruguay

A Two-Week Treatment with Plant Extracts Changes Gut Microbiota, Caecum Metabolome, and Markers of Lipid Metabolism in ob/ob Mice

artículo científico publicado en 2019

A role for adipocyte-derived lipopolysaccharide-binding protein in inflammation- and obesity-associated adipose tissue dysfunction

artículo científico publicado en 2013

A role for the gut-to-brain GLP-1-dependent axis in the control of metabolism.

artículo científico publicado en 2009

Accelerated lipid-induced atherogenesis in galectin-3-deficient mice: role of lipoxidation via receptor-mediated mechanisms.

artículo científico publicado en 2009

Active thrombin produced by the intestinal epithelium controls mucosal biofilms

artículo científico publicado en 2019

Adiponectin isoforms are not associated with the severity of coronary atherosclerosis but with undiagnosed diabetes in patients affected by stable CAD.

artículo científico publicado en 2008

Associations between hepatic miRNA expression, liver triacylglycerols and gut microbiota during metabolic adaptation to high-fat diet in mice

artículo científico publicado en 2017

CD14 modulates inflammation-driven insulin resistance

artículo científico publicado en 2011

Changes in blood microbiota profiles associated with liver fibrosis in obese patients: A pilot analysis

artículo científico publicado en 2016

Circulating lipopolysaccharide-binding protein (LBP) as a marker of obesity-related insulin resistance

artículo científico publicado en 2011

Defective NOD2 peptidoglycan sensing promotes diet-induced inflammation, dysbiosis, and insulin resistance

artículo científico publicado en 2015

Evolution of Gut Microbiome and Metabolome in Suspected Necrotizing Enterocolitis: A Case-Control Study

scientific article published on 17 July 2020

Far from the eyes, close to the heart: dysbiosis of gut microbiota and cardiovascular consequences

artículo científico publicado en 2014

Galectin-3 ablation protects mice from diet-induced NASH: a major scavenging role for galectin-3 in liver.

artículo científico publicado en 2010

Gestational diabetes is associated with changes in placental microbiota and microbiome

artículo científico publicado en 2016

Gut Microbiota Interacts With Brain Microstructure and Function

artículo científico publicado en 2015

Gut Microbiota Interacts with Markers of Adipose Tissue Browning, Insulin Action and Plasma Acetate in Morbid Obesity.

artículo científico publicado en 2017

Gut microbiota and diabetes: from pathogenesis to therapeutic perspective.

artículo científico publicado en 2011

High-fat diet induces periodontitis in mice through lipopolysaccharides (LPS) receptor signaling: protective action of estrogens

artículo científico publicado en 2012

Inflammation and insulin resistance exert dual effects on adipose tissue tumor protein 53 expression

artículo científico publicado en 2013

Intestinal MicrobiOMICS to define health and disease in human and mice.

artículo científico

Intestinal microbiota and novel therapeutic perspectives for the treatment of metabolic diseases

artículo científico publicado en 2013

Intestinal microflora and metabolic diseases.

artículo científico publicado en 2009

Intestinal permeability--a new target for disease prevention and therapy

artículo científico publicado en 2014

Involvement of tissue bacteria in the onset of diabetes in humans: evidence for a concept

artículo científico publicado en 2011

Lipid-induced peroxidation in the intestine is involved in glucose homeostasis imbalance in mice

artículo científico publicado en 2011

Managing the manager: gut microbes, stem cells and metabolism

artículo científico publicado en 2014

Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota

artículo científico publicado en 2011

Metabolic endotoxemia directly increases the proliferation of adipocyte precursors at the onset of metabolic diseases through a CD14-dependent mechanism

artículo científico publicado en 2013

Metabolic therapy at the edge between human hosts and gut microbes

artículo científico publicado en 2012

Metagenome and metabolism: the tissue microbiota hypothesis.

artículo científico publicado en 2013

Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug

artículo científico publicado en 2017

Mice heterozygous for tumor necrosis factor-alpha converting enzyme are protected from obesity-induced insulin resistance and diabetes.

artículo científico publicado en 2007

Microbes on-air: gut and tissue microbiota as targets in type 2 diabetes

artículo científico publicado en 2012

Molecular Paths linking Metabolic Diseases, Gut Microbiota Dysbiosis and Enterobacteria Infections.

artículo científico publicado en 2018

Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women

artículo científico publicado en 2018

Oral health and microbiota status in professional rugby players: A case-control study

article

Oral microbiota-induced periodontitis: a new risk factor of metabolic diseases

artículo científico publicado en 2019

Periodontal dysbiosis linked to periodontitis is associated with cardiometabolic adaptation to high-fat diet in mice.

artículo científico publicado en 2016

Periodontitis induced by Porphyromonas gingivalis drives periodontal microbiota dysbiosis and insulin resistance via an impaired adaptive immune response.

artículo científico publicado en 2016

Publisher Correction: Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women

artículo científico publicado en 2018

Resveratrol increases glucose induced GLP-1 secretion in mice: a mechanism which contributes to the glycemic control

artículo científico publicado en 2011

SCFAs - the thin microbial metabolic line between good and bad

artículo científico publicado en 2019

Structure function relationships in three lipids A from the Ralstonia genus rising in obese patients

scientific article published on 28 January 2019

Study of lactoferrin gene expression in human and mouse adipose tissue, human preadipocytes and mouse 3T3-L1 fibroblasts. Association with adipogenic and inflammatory markers

artículo científico publicado en 2013

Targeting the association of calgranulin B (S100A9) with insulin resistance and type 2 diabetes

artículo científico publicado en 2012

The Genotoxin Colibactin Shapes Gut Microbiota in Mice

artículo científico publicado en 2020

The Gut Microbiota Regulates Intestinal CD4 T Cells Expressing RORγt and Controls Metabolic Disease

artículo científico publicado en 2015

The gut microbiota ecology: a new opportunity for the treatment of metabolic diseases?

scientific article published on June 2009

The gut microbiota profile is associated with insulin action in humans.

artículo científico publicado en 2012

Transfer of dysbiotic gut microbiota has beneficial effects on host liver metabolism

artículo científico publicado en 2017

Young microbes for adult obesity.

artículo científico publicado en 2016

[Impact of periodontal disease on arterial pressure in diabetic mice]

artículo científico publicado en 2012

Lista de obras de M Serino

A Two-Week Treatment with Plant Extracts Changes Gut Microbiota, Caecum Metabolome, and Markers of Lipid Metabolism in ob/ob Mice

A role for adipocyte-derived lipopolysaccharide-binding protein in inflammation- and obesity-associated adipose tissue dysfunction

A role for the gut-to-brain GLP-1-dependent axis in the control of metabolism.

Accelerated lipid-induced atherogenesis in galectin-3-deficient mice: role of lipoxidation via receptor-mediated mechanisms.

Active thrombin produced by the intestinal epithelium controls mucosal biofilms

Adiponectin isoforms are not associated with the severity of coronary atherosclerosis but with undiagnosed diabetes in patients affected by stable CAD.

Associations between hepatic miRNA expression, liver triacylglycerols and gut microbiota during metabolic adaptation to high-fat diet in mice

CD14 modulates inflammation-driven insulin resistance

Changes in blood microbiota profiles associated with liver fibrosis in obese patients: A pilot analysis

Circulating lipopolysaccharide-binding protein (LBP) as a marker of obesity-related insulin resistance

Defective NOD2 peptidoglycan sensing promotes diet-induced inflammation, dysbiosis, and insulin resistance

Evolution of Gut Microbiome and Metabolome in Suspected Necrotizing Enterocolitis: A Case-Control Study

Far from the eyes, close to the heart: dysbiosis of gut microbiota and cardiovascular consequences

Galectin-3 ablation protects mice from diet-induced NASH: a major scavenging role for galectin-3 in liver.

Gestational diabetes is associated with changes in placental microbiota and microbiome

Gut Microbiota Interacts With Brain Microstructure and Function

Gut Microbiota Interacts with Markers of Adipose Tissue Browning, Insulin Action and Plasma Acetate in Morbid Obesity.

Gut microbiota and diabetes: from pathogenesis to therapeutic perspective.

High-fat diet induces periodontitis in mice through lipopolysaccharides (LPS) receptor signaling: protective action of estrogens

Inflammation and insulin resistance exert dual effects on adipose tissue tumor protein 53 expression

Intestinal MicrobiOMICS to define health and disease in human and mice.

Intestinal microbiota and novel therapeutic perspectives for the treatment of metabolic diseases

Intestinal microflora and metabolic diseases.

Intestinal permeability--a new target for disease prevention and therapy

Involvement of tissue bacteria in the onset of diabetes in humans: evidence for a concept

Lipid-induced peroxidation in the intestine is involved in glucose homeostasis imbalance in mice

Managing the manager: gut microbes, stem cells and metabolism

Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota

Metabolic endotoxemia directly increases the proliferation of adipocyte precursors at the onset of metabolic diseases through a CD14-dependent mechanism

Metabolic therapy at the edge between human hosts and gut microbes

Metagenome and metabolism: the tissue microbiota hypothesis.

Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug

Mice heterozygous for tumor necrosis factor-alpha converting enzyme are protected from obesity-induced insulin resistance and diabetes.

Microbes on-air: gut and tissue microbiota as targets in type 2 diabetes

Molecular Paths linking Metabolic Diseases, Gut Microbiota Dysbiosis and Enterobacteria Infections.

Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women

Oral health and microbiota status in professional rugby players: A case-control study

Oral microbiota-induced periodontitis: a new risk factor of metabolic diseases

Periodontal dysbiosis linked to periodontitis is associated with cardiometabolic adaptation to high-fat diet in mice.

Periodontitis induced by Porphyromonas gingivalis drives periodontal microbiota dysbiosis and insulin resistance via an impaired adaptive immune response.

Publisher Correction: Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women

Resveratrol increases glucose induced GLP-1 secretion in mice: a mechanism which contributes to the glycemic control

SCFAs - the thin microbial metabolic line between good and bad

Structure function relationships in three lipids A from the Ralstonia genus rising in obese patients

Study of lactoferrin gene expression in human and mouse adipose tissue, human preadipocytes and mouse 3T3-L1 fibroblasts. Association with adipogenic and inflammatory markers

Targeting the association of calgranulin B (S100A9) with insulin resistance and type 2 diabetes

The Genotoxin Colibactin Shapes Gut Microbiota in Mice

The Gut Microbiota Regulates Intestinal CD4 T Cells Expressing RORγt and Controls Metabolic Disease

The gut microbiota ecology: a new opportunity for the treatment of metabolic diseases?

The gut microbiota profile is associated with insulin action in humans.

Transfer of dysbiotic gut microbiota has beneficial effects on host liver metabolism

Young microbes for adult obesity.

[Impact of periodontal disease on arterial pressure in diabetic mice]